药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Lumiracoxib
Prenylamine
The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Vemurafenib.
Lumiracoxib
Terlipressin
The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Vemurafenib.
Lumiracoxib
Aceprometazine
The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Vemurafenib.
Lumiracoxib
Probucol
The risk or severity of QTc prolongation can be increased when Probucol is combined with Vemurafenib.
Lumiracoxib
Lumacaftor
The serum concentration of Vemurafenib can be decreased when it is combined with Lumacaftor.
Lumiracoxib
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Vemurafenib.
Lumiracoxib
Perampanel
The metabolism of Perampanel can be increased when combined with Vemurafenib.
Lumiracoxib
Metreleptin
The metabolism of Vemurafenib can be increased when combined with Metreleptin.
Lumiracoxib
Cyclopentamine
The risk or severity of adverse effects can be increased when Vemurafenib is combined with Cyclopentamine.
Lumiracoxib
Hexamethonium
The risk or severity of adverse effects can be increased when Vemurafenib is combined with Hexamethonium.
Lumiracoxib
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Vemurafenib.
Lumiracoxib
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Vemurafenib.
Lumiracoxib
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Vemurafenib.
Lumiracoxib
Armodafinil
The metabolism of Vemurafenib can be increased when combined with Armodafinil.
Lumiracoxib
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vemurafenib.
Lumiracoxib
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Vemurafenib.
Carbetocin
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Teriflunomide.
Carbetocin
Inebilizumab
The risk or severity of infection can be increased when Teriflunomide is combined with Inebilizumab.
Carbetocin
Capmatinib
The serum concentration of Teriflunomide can be increased when it is combined with Capmatinib.
Carbetocin
Ozanimod
Teriflunomide may decrease the excretion rate of Ozanimod which could result in a higher serum level.